Letter: Benefits and drawbacks of electric shock therapy
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: I must disagree with Lucy Johnstone's assertion (letter, 14 December) that electroconvulsive therapy (ECT) lacks a rationale for its use and convincing evidence for its efficacy. This blanket statement does not hold water.
Over the last 16 years an impressive body of evidence has accrued that ECT has well-defined, although complex, effects upon brain function, which are very similar to those of anti-depressant drugs, and which do indeed provide a reasonable rationale for its use in the treatment of patients with severe depression.
Its efficacy has been shown by numerous carefully conducted clinical studies in depressive illness, and detailed guidelines for its use in this condition have been published by the Royal College of Psychiatrists. When used properly, ECT can bring relief to seriously depressed patients.
Future research into the biological nature of mental illness and its treatment may clarify further how ECT brings about the changes in brain function through which it is thought to produce its therapeutic effects, and allow the development of treatments lacking the adverse effects of ECT.
Yours sincerely,
D. G. GRAHAME-SMITH
Rhodes Professor of
Clinical Pharmacology
Radcliffe Infirmary
Oxford
14 December
The writer is honorary director of the Medical Research Council Unit of Clinical Pharmacology.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments